A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Public ClinicalTrials.gov record NCT06356571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-arm, Open-label, Phase 2 Study Evaluating Subcutaneous Administration of Isatuximab, Administered by an On Body Delivery System, in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)
Study identification
- NCT ID
- NCT06356571
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- Acetaminophen Drug
- Carfilzomib Drug
- Dexamethasone Drug
- Diphenhydramine Drug
- Isatuximab SC-OBDS Drug
- Methylprednisolone Drug
- Montelukast Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 16, 2025
- Primary completion
- Jan 7, 2027
- Completion
- Jul 14, 2027
- Last update posted
- Feb 22, 2026
2025 – 2027
United States locations
- U.S. sites
- 34
- U.S. states
- 18
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic in Arizona - Phoenix- Site Number : 8400058 | Phoenix | Arizona | 85054 | Recruiting |
| Los Angeles Hematology Oncology Medical Group- Site Number : 8400027 | Los Angeles | California | 90017 | Recruiting |
| Private Practice - Dr. James R. Berenson- Site Number : 8400044 | West Hollywood | California | 90069 | Recruiting |
| Smilow Cancer Center at Yale-New Haven- Site Number : 8400020 | New Haven | Connecticut | 06511 | Recruiting |
| Maryland Oncology Hematology- Site Number : 8400038 | Washington D.C. | District of Columbia | 20017 | Recruiting |
| Life Clinical Trials - Coral Springs- Site Number : 8400055 | Coral Springs | Florida | 33071 | Recruiting |
| Center for Rheumatology, Immunology and Arthritis- Site Number : 8400031 | Fort Lauderdale | Florida | 33309 | Recruiting |
| Mayo Clinic in Florida- Site Number : 8400002 | Jacksonville | Florida | 32224 | Recruiting |
| The Oncology Institute of Hope & Innovation - Lakeland- Site Number : 8400054 | Lakeland | Florida | 33812 | Recruiting |
| D&H Pompano Research Center- Site Number : 8400049 | Margate | Florida | 33063 | Recruiting |
| Millennium Oncology - Pembroke Pines- Site Number : 8400011 | Pembroke Pines | Florida | 33024 | Recruiting |
| BRCR Global- Site Number : 8400008 | Plantation | Florida | 33322 | Recruiting |
| Florida Cancer Specialists - North- Site Number : 8400030 | St. Petersburg | Florida | 33705 | Recruiting |
| Pontchartrain Cancer Center - Covington- Site Number : 8400046 | Covington | Louisiana | 70433 | Recruiting |
| Beth Israel Deaconess Medical Center - Boston- Site Number : 8400005 | Boston | Massachusetts | 02215 | Recruiting |
| Michigan Hematology & Oncology Consultants - Dearborn- Site Number : 8400036 | Dearborn | Michigan | 48126 | Recruiting |
| Hematology Oncology Consultants - Royal Oak- Site Number : 8400039 | Royal Oak | Michigan | 48073 | Recruiting |
| Alliance for Multispeciality Research - Kansas City- Site Number : 8400056 | Kansas City | Missouri | 64114 | Recruiting |
| Washington University- Site Number : 8400007 | St Louis | Missouri | 63110 | Recruiting |
| Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400021 | Hackensack | New Jersey | 07601 | Recruiting |
| San Juan Oncology Associates- Site Number : 8400016 | Farmington | New Mexico | 87401 | Recruiting |
| Memorial Sloan Kettering Cancer Center - New York - York Avenue- Site Number : 8400003 | New York | New York | 10065 | Recruiting |
| Duke University Medical Center- Site Number : 8400018 | Durham | North Carolina | 27710 | Recruiting |
| Gabrail Cancer Center- Site Number : 8400010 | Canton | Ohio | 44718 | Recruiting |
| University of Cincinnati Medical Center- Site Number : 8400043 | Cincinnati | Ohio | 45219 | Recruiting |
| Oncology Hematology Care - Kenwood- Site Number : 8400014 | Cincinnati | Ohio | 45236 | Recruiting |
| Roper Saint Francis Healthcare- Site Number : 8400013 | Charleston | South Carolina | 29401 | Recruiting |
| Prisma Health Cancer Institute - Greenville- Site Number : 8400019 | Greenville | South Carolina | 29615 | Recruiting |
| Gibbs Cancer Center & Research Institute - Spartanburg- Site Number : 8400001 | Spartanburg | South Carolina | 29303 | Recruiting |
| Tennessee Cancer Specialists - Knoxville - Old Weisgarber Road- Site Number : 8400035 | Knoxville | Tennessee | 37909 | Recruiting |
| University of Tennessee Medical Center- Site Number : 8400006 | Knoxville | Tennessee | 37920 | Recruiting |
| Tennessee Oncology Nashville- Site Number : 8400012 | Nashville | Tennessee | 37203 | Recruiting |
| Northern Virginia Oncology Group- Site Number : 8400045 | Fairfax | Virginia | 22031 | Recruiting |
| SSM Health Dean Medical Group - Wisconsin - Madison- Site Number : 8400009 | Madison | Wisconsin | 53715 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06356571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06356571 live on ClinicalTrials.gov.